{
  "openalex_id": "W3200249233",
  "doi": "https://doi.org/10.12788/fp.0169",
  "title": "Comparison of Renal Function Between Tenofovir Disoproxil Fumarate and Other Nucleos(t)ide Reverse Transcriptase Inhibitors in Patients With Hepatitis B Virus Infection",
  "abstract": "Nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) have become a standard treatment for both HIV and hepatitis B virus (HBV) infections. Tenofovir disoproxil fumarate (TDF) has been associated with kidney injury and possible long-term damage in patients with HIV. Few studies have examined whether this holds true for patients treated for HBV.Data were gathered from the Veterans Health Administration Corporate Data Warehouse between July 1, 2005 and July 31, 2015. Patients aged â‰¥ 18 years with HBV infection and prescribed a NRTI for > 1 month were included in the study and followed for 36 months. Patients with HIV infection were excluded, and patients treated with combination TDF/emtricitabine were analyzed separately from patients receiving only TDF. A linear mixed model was used to examine the effects of time and specific agent on renal function, which was measured with estimated glomerular filtration rate (eGFR) at various time intervals.There were 413 incidences of NRTI use in 308 subjects during the 10 years of the study with 39 cases of TDF use. There was a significant fixed effect of time, with eGFR reduction of 4.6 mL/min (P < .001) over the course of the study for the full cohort, but the effects of each medication were not significant.This multicenter, retrospective study did not demonstrate an association between TDF use and a greater degree of kidney injury compared with other NRTIs in patients with HBV, but further studies are warranted.",
  "authors": [
    {
      "display_name": "Matthew G Fischer",
      "id": "A5103999946",
      "orcid": null,
      "institutions": [
        {
          "id": "I24571045",
          "display_name": "University of North Dakota",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Matthew G Fischer"
    },
    {
      "display_name": "William P. Newman",
      "id": "A5073301697",
      "orcid": "https://orcid.org/0000-0002-5712-9265",
      "institutions": [
        {
          "id": "I24571045",
          "display_name": "University of North Dakota",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "William Newman"
    },
    {
      "display_name": "Kimberly Hammer",
      "id": "A5001405281",
      "orcid": "https://orcid.org/0000-0003-2328-6964",
      "institutions": [
        {
          "id": "I24571045",
          "display_name": "University of North Dakota",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Kimberly Hammer"
    },
    {
      "display_name": "Melissa Rohrich",
      "id": "A5024541151",
      "orcid": "https://orcid.org/0000-0001-6564-9140",
      "institutions": [
        {
          "id": "I24571045",
          "display_name": "University of North Dakota",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Melissa Rohrich"
    },
    {
      "display_name": "Tze Shien Lo",
      "id": "A5066894236",
      "orcid": "https://orcid.org/0000-0003-4737-9954",
      "institutions": [
        {
          "id": "I24571045",
          "display_name": "University of North Dakota",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Tze Shien Lo"
    }
  ],
  "publication_year": 2021,
  "publication_date": "2021-08-01",
  "type": "article",
  "cited_by_count": 3,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S4306510379",
    "display_name": "Federal practitioner",
    "issn_l": "1078-4497",
    "issn": [
      "1078-4497",
      "1945-337X"
    ],
    "type": "journal",
    "host_organization": null
  },
  "volume": null,
  "issue": "38 (8)",
  "first_page": null,
  "last_page": null,
  "open_access": {
    "is_oa": true,
    "oa_status": "bronze",
    "oa_url": "https://cdn.mdedge.com/files/s3fs-public/issues/articles/fdp03808362_0.pdf",
    "any_repository_has_fulltext": true
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.86508465
    },
    {
      "id": "C2779778239",
      "display_name": "Emtricitabine",
      "level": 5,
      "score": 0.77889526
    },
    {
      "id": "C2779344132",
      "display_name": "Tenofovir",
      "level": 3,
      "score": 0.76952636
    },
    {
      "id": "C159641895",
      "display_name": "Renal function",
      "level": 2,
      "score": 0.7160443
    },
    {
      "id": "C2777351918",
      "display_name": "Reverse-transcriptase inhibitor",
      "level": 5,
      "score": 0.6227663
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.6097384
    },
    {
      "id": "C2780593183",
      "display_name": "Hepatitis B virus",
      "level": 3,
      "score": 0.5806895
    },
    {
      "id": "C2776175608",
      "display_name": "Entecavir",
      "level": 5,
      "score": 0.53216445
    },
    {
      "id": "C2777382497",
      "display_name": "Hepatitis B",
      "level": 2,
      "score": 0.5057771
    },
    {
      "id": "C201903717",
      "display_name": "Cohort study",
      "level": 2,
      "score": 0.45626354
    },
    {
      "id": "C2780306776",
      "display_name": "Creatinine",
      "level": 2,
      "score": 0.4177815
    },
    {
      "id": "C167135981",
      "display_name": "Retrospective cohort study",
      "level": 2,
      "score": 0.41353798
    },
    {
      "id": "C156719811",
      "display_name": "Reverse transcriptase",
      "level": 4,
      "score": 0.41225308
    },
    {
      "id": "C90924648",
      "display_name": "Gastroenterology",
      "level": 1,
      "score": 0.38078347
    },
    {
      "id": "C2777869810",
      "display_name": "Lamivudine",
      "level": 4,
      "score": 0.3652172
    },
    {
      "id": "C3013748606",
      "display_name": "Human immunodeficiency virus (HIV)",
      "level": 2,
      "score": 0.35992068
    },
    {
      "id": "C159047783",
      "display_name": "Virology",
      "level": 1,
      "score": 0.35081136
    },
    {
      "id": "C142462285",
      "display_name": "Viral load",
      "level": 3,
      "score": 0.2481929
    },
    {
      "id": "C2993143319",
      "display_name": "Antiretroviral therapy",
      "level": 4,
      "score": 0.2328029
    },
    {
      "id": "C2522874641",
      "display_name": "Virus",
      "level": 2,
      "score": 0.22729343
    },
    {
      "id": "C86803240",
      "display_name": "Biology",
      "level": 0,
      "score": 0.08434227
    },
    {
      "id": "C49105822",
      "display_name": "Polymerase chain reaction",
      "level": 3,
      "score": 0.071245074
    },
    {
      "id": "C55493867",
      "display_name": "Biochemistry",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C104317684",
      "display_name": "Gene",
      "level": 2,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T10340",
      "display_name": "Hepatitis B Virus Studies",
      "score": 0.9999
    },
    {
      "id": "T10151",
      "display_name": "Hepatitis C virus research",
      "score": 0.9994
    },
    {
      "id": "T10526",
      "display_name": "HIV/AIDS drug development and treatment",
      "score": 0.9986
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.12788/fp.0169",
  "pdf_url": "https://cdn.mdedge.com/files/s3fs-public/issues/articles/fdp03808362_0.pdf",
  "retrieved_date": "2025-07-30T14:57:12.941635",
  "source_database": "OpenAlex"
}